Published in Am J Public Health on January 01, 1995
Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City. Public Health Rep (1998) 1.98
Retention, HIV risk, and illicit drug use during treatment: methadone dose and visit frequency. Am J Public Health (1998) 1.54
The newer Opioid Agonist Treatment with lower substitutive opiate doses is associated with better toxicology outcome than the older Harm Reduction Treatment. Ann Gen Psychiatry (2016) 1.40
Structural-level factors affecting implementation of the methadone maintenance therapy program in China. J Subst Abuse Treat (2009) 1.31
Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine β-hydroxylase. Biol Psychiatry (2012) 1.27
Pharmacotherapy in the treatment of addiction: methadone. J Addict Dis (2010) 1.23
The safety and efficacy of varenicline in cocaine using smokers maintained on methadone: a pilot study. Am J Addict (2010) 1.15
Randomized, double blind, placebo-controlled trial of disulfiram for the treatment of cocaine dependence in methadone-stabilized patients. Drug Alcohol Depend (2010) 1.08
Gender differences in illicit substance use among middle-aged drug users with or at risk for HIV infection. Clin Infect Dis (2006) 1.02
Sex differences in outcomes of methadone maintenance treatment for opioid addiction: a systematic review protocol. Syst Rev (2014) 1.01
Substance abuse treatment in human immunodeficiency virus: the role of patient-provider discussions. J Subst Abuse Treat (2008) 1.01
Heroin and cocaine co-use in a group of injection drug users in Montréal. J Psychiatry Neurosci (2004) 0.98
Interdisciplinary mixed methods research with structurally vulnerable populations: case studies of injection drug users in San Francisco. Int J Drug Policy (2013) 0.98
The therapeutic workplace to promote treatment engagement and drug abstinence in out-of-treatment injection drug users: a randomized controlled trial. Prev Med (2014) 0.97
Discrete-trials heroin self-administration produces sensitization to the reinforcing effects of cocaine in rats. Psychopharmacology (Berl) (2006) 0.86
Methadone maintenance treatment in China: perceived challenges from the perspectives of service providers and patients. J Public Health (Oxf) (2012) 0.85
Association between methadone dose and concomitant cocaine use in methadone maintenance treatment: a register-based study. Subst Abuse Treat Prev Policy (2014) 0.85
The impact of dispensing fees on compliance with opioid substitution therapy: a mixed methods study. Subst Abuse Treat Prev Policy (2014) 0.84
A randomized investigation of methadone doses at or over 100 mg/day, combined with contingency management. Drug Alcohol Depend (2012) 0.84
Social defeat stress in rats: escalation of cocaine and "speedball" binge self-administration, but not heroin. Psychopharmacology (Berl) (2011) 0.83
Rates of mood and anxiety disorders and contributors to continued heroin use in methadone maintenance patients: A comparison by HIV status. Neurobehav HIV Med (2010) 0.81
Exercise decreases speedball self-administration. Life Sci (2014) 0.81
ANKK1 and DRD2 pharmacogenetics of disulfiram treatment for cocaine abuse. Pharmacogenet Genomics (2013) 0.79
Correlates of Nine-Month Retention following Interim Buprenorphine-Naloxone Treatment in Opioid Dependence: A Pilot Study. J Addict (2016) 0.76
Buprenorphine treatment outcomes among opioid-dependent cocaine users and non-users. Am J Addict (2013) 0.76
Behavioral factors predicting response to employment-based reinforcement of cocaine abstinence in methadone patients. Transl Issues Psychol Sci (2016) 0.75
Problem drug use the public health imperative: what some of the literature says. Subst Abuse Treat Prev Policy (2009) 0.75
Psychoactive Substance Use among Methadone Maintenance Therapy Clients in China. Int J Ment Health Addict (2017) 0.75
Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA (1989) 5.66
Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med (1989) 4.72
Cocaine and other stimulants. Actions, abuse, and treatment. N Engl J Med (1988) 3.98
Narcotic blockade. Arch Intern Med (1966) 3.80
Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations. Arch Gen Psychiatry (1986) 3.74
Reducing the risk of AIDS through methadone maintenance treatment. J Health Soc Behav (1988) 3.14
Variations in methadone treatment practices. Results from a national study. JAMA (1992) 2.83
Implications of methadone maintenance for theories of narcotic addiction. JAMA (1988) 2.28
Role of drug-abuse treatment in limiting the spread of AIDS. Rev Infect Dis (1988) 1.76
Methadone concentrations in plasma and their relationship to drug dosage. Clin Chem (1991) 1.68
Predicting cocaine use among methadone patients: analysis of findings from a national study. Hosp Community Psychiatry (1992) 1.61
Methadone treatment and the acquired immunodeficiency syndrome epidemic. JAMA (1989) 1.60
Dose-response effects of methadone in the treatment of opioid dependence. Ann Intern Med (1993) 1.41
Cocaine use by clients in methadone programs: significance, scope, and behavioral interventions. J Subst Abuse Treat (1991) 1.20
Patterns of cocaine use among methadone clients. Int J Addict (1985) 1.15
Chronic cocaine alters brain mu opioid receptors. Brain Res (1992) 1.11
Methadone disposition in patients with chronic liver disease. Clin Pharmacol Ther (1981) 1.10
Methadone dose and heroin use during maintenance treatment. Addiction (1993) 1.04
ACTH, cortisol and beta-endorphin response to metyrapone testing during chronic methadone maintenance treatment in humans. Neuropeptides (1984) 1.02
Neurobiology of abused drugs. Opioids and stimulants. J Nerv Ment Dis (1990) 0.93
Inadequate plasma concentrations in some high-dose methadone maintenance patients. Am J Psychiatry (1987) 0.86
Abnormal adrenal gland metabolism in opioid addicts: implications for clinical treatment. J Psychoactive Drugs (1992) 0.82
Advocacy for methadone treatment. Ann Intern Med (1990) 0.80
A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med (1989) 10.98
Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med (1984) 6.11
Association of Streptococcus bovis with carcinoma of the colon. N Engl J Med (1977) 5.86
PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol (1997) 5.76
Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA (2001) 5.52
Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis (2001) 5.43
Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med (1989) 4.72
Transmission of the human immunodeficiency virus. N Engl J Med (1987) 4.17
Trust and the acceptance of and adherence to antiretroviral therapy. J Acquir Immune Defic Syndr (2001) 3.86
Immunodeficiency in female sexual partners of men with the acquired immunodeficiency syndrome. N Engl J Med (1983) 3.67
Detection and treatment of hypertension at the work site. N Engl J Med (1975) 3.43
Medical care for injection-drug users with human immunodeficiency virus infection. N Engl J Med (1994) 3.25
Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J Exp Med (2000) 3.15
Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J Immunol (1996) 2.86
Intravenous drug abusers and the acquired immunodeficiency syndrome (AIDS). Demographic, drug use, and needle-sharing patterns. Arch Intern Med (1985) 2.62
Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis (2001) 2.51
Predictors of HIV infection among newly sentenced male prisoners. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 2.47
Acceptance and adherence with antiretroviral therapy among HIV-infected women in a correctional facility. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 2.43
Knowledge of HIV antibody status and decisions to continue or terminate pregnancy among intravenous drug users. JAMA (1989) 2.41
Lack of transmission of HTLV-III/LAV infection to household contacts of patients with AIDS or AIDS-related complex with oral candidiasis. N Engl J Med (1986) 2.40
Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. N Engl J Med (1992) 2.36
The deamination of cytidine and cytosine by acidic buffer solutions. Mutagenic implications. Biochemistry (1966) 2.30
The Yugoslavia Prospective Lead Study: contributions of prenatal and postnatal lead exposure to early intelligence. Neurotoxicol Teratol (2001) 2.25
Disease progression and early viral dynamics in human immunodeficiency virus-infected children exposed to zidovudine during prenatal and perinatal periods. J Infect Dis (2000) 2.25
Survival differences in patients with AIDS. J Acquir Immune Defic Syndr (1991) 2.23
Cocaine and tobacco use and the risk of spontaneous abortion. N Engl J Med (1999) 2.20
Ephrin-B reverse signaling is mediated by a novel PDZ-RGS protein and selectively inhibits G protein-coupled chemoattraction. Cell (2001) 2.20
High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. JAMA (1992) 2.19
Streptococcus bovis septicemia and carcinoma of the colon. Ann Intern Med (1979) 2.06
Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: an alternate model of care. Int J Tuberc Lung Dis (2012) 2.03
Smoking, alcohol and reproduction. Am J Public Health (1983) 2.00
Major depressive disorder in the 6 months after miscarriage. JAMA (1997) 1.99
Effect of maternal age on autosomal trisomies. Ann Hum Genet (1980) 1.98
Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City. Public Health Rep (1998) 1.98
Drinking during pregnancy and spontaneous abortion. Lancet (1980) 1.96
Effects of HIV infection on the serologic manifestations and response to treatment of syphilis in intravenous drug users. Ann Intern Med (1993) 1.92
Depressive symptoms in women in the six months after miscarriage. Am J Obstet Gynecol (1992) 1.84
Mosaic autosomal trisomy in cultures from spontaneous abortions. Am J Hum Genet (1978) 1.80
Maternal smoking and trisomy among spontaneously aborted conceptions. Am J Hum Genet (1983) 1.80
Multicenter evaluation of hepatitis C RNA levels among female injection drug users. J Infect Dis (2001) 1.77
Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS. AIDS (1988) 1.75
Smoking: a risk factor for spontaneous abortion. N Engl J Med (1977) 1.73
Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women. HIV Epidemiology Research Study Group. Clin Infect Dis (1999) 1.69
Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women. AIDS (2001) 1.68
Prospective study of human immunodeficiency virus infection and pregnancy outcomes in intravenous drug users. JAMA (1989) 1.63
Utilization of on-site primary care services by HIV-seropositive and seronegative drug users in a methadone maintenance program. Public Health Rep (1993) 1.58
The era of adherence to HIV therapy. Ann Intern Med (1998) 1.55
Factors associated with unrecognized HIV-1 infection in an inner-city emergency department. Ann Emerg Med (1996) 1.54
A prospective study of HIV disease progression in female and male drug users. AIDS (1999) 1.54
An international collaborative study of the effects of coinfection with human T-lymphotropic virus type II on human immunodeficiency virus type 1 disease progression in injection drug users. J Infect Dis (1996) 1.51
Longitudinal analysis of bacterial vaginosis: findings from the HIV epidemiology research study. Obstet Gynecol (2001) 1.51
Lack of association of induration size with HIV infection among drug users reacting to tuberculin. Am J Respir Crit Care Med (1996) 1.47
Prevalence of cutaneous disease in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex. J Am Acad Dermatol (1987) 1.47
Criteria for the diagnosis of infective endocarditis. Clin Infect Dis (1994) 1.44
Tuberculosis infection control in rural South Africa: survey of knowledge, attitude and practice in hospital staff. J Hosp Infect (2011) 1.44
Low occupational risk of human immunodeficiency virus infection among dental professionals. N Engl J Med (1988) 1.43
Does the karyotype of a spontaneous abortion predict the karyotype of a subsequent abortion? Evidence from 273 women with two karyotyped spontaneous abortions. Am J Hum Genet (1987) 1.41
Determinants of elevated blood lead during pregnancy in a population surrounding a lead smelter in Kosovo, Yugoslavia. Environ Health Perspect (1990) 1.41
Chimerism does not predict for outcome after alemtuzumab based conditioning. Bone Marrow Transplant (2007) 1.40
Activities of antifolate, antiviral, and other drugs in an immunosuppressed rat model of Pneumocystis carinii pneumonia. Antimicrob Agents Chemother (1992) 1.40
The relationship between maternal age and chromosome size in autosomal trisomy. Am J Hum Genet (1986) 1.40
High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection. Am J Obstet Gynecol (1991) 1.39
High prevalence of insomnia in an outpatient population with HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.38
Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting. Int J Tuberc Lung Dis (2012) 1.37
Early detection of perinatal human immunodeficiency virus (HIV) type 1 infection using HIV RNA amplification and detection. New York City Perinatal HIV Transmission Collaborative Study. J Infect Dis (1997) 1.36
Indoor airborne bacterial communities are influenced by ventilation, occupancy, and outdoor air source. Indoor Air (2013) 1.36
Cervical cytologic abnormalities and papillomavirus in women infected with human immunodeficiency virus. J Acquir Immune Defic Syndr (1990) 1.36
Spontaneous abortion as a screening device. The effect of fetal survival on the incidence of birth defects. Am J Epidemiol (1975) 1.33
Cigarettes, alcohol and marijuana: varying associations with birthweight. Int J Epidemiol (1987) 1.32
Antibiotic activity in vitro against methicillin-resistant Staphylococcus epidermidis and therapy of an experimental infection. Antimicrob Agents Chemother (1979) 1.30
In vivo antagonism with zidovudine plus stavudine combination therapy. J Infect Dis (2000) 1.30
The treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Arch Intern Med (1985) 1.29